You are here

  • Home
  • Archive
  • Volume 70, Issue 2
  • No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir

Article metrics

Article menu
Download PDFPDF
Hepatology
Original research
No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir

 

Online download statistics by month:

Online download statistics by month: March 2020 to April 2025

AbstractFullPdf
Mar 20202292112
Apr 20201356192112
May 20205145029
Jun 20202682411
Jul 2020139167
Aug 20201091411
Sep 2020872419
Oct 20201131713
Nov 2020117137
Dec 2020991916
Jan 20217239360
Feb 20214533536
Mar 20212382621
Apr 20212362116
May 2021451112
Jun 2021261916
Jul 20211298
Aug 202115910
Sep 202124156
Oct 2021149108
Nov 2021127224
Dec 202183104
Jan 2022151238
Feb 202285133
Mar 2022109228
Apr 202210592
May 202215142
Jun 20227872
Jul 20227982
Aug 2022106103
Sep 20229093
Oct 202211963
Nov 20229150
Dec 20226784
Jan 20236674
Feb 20239200
Mar 20238674
Apr 20234753
May 20234131
Jun 20233423
Jul 20232921
Aug 20233240
Sep 202368119
Oct 20234330
Nov 20235544
Dec 202311911
Jan 202412814
Feb 20245432
Mar 20245942
Apr 20249351
May 20244322
Jun 20242634
Jul 20242700
Aug 20243954
Sep 20245544
Oct 20245521
Nov 20246710
Dec 20244010
Jan 20258384
Feb 2025810
Mar 2025600
Apr 2025401
Total7892883537